Q BioMed Inc.
QBIO · OTC
2/28/2023 | 11/30/2022 | 8/31/2022 | 5/31/2022 | |
|---|---|---|---|---|
| Market Cap | $1,305 | $717 | $1,302 | $3,598 |
| - Cash | $23 | $50 | $138 | $27 |
| + Debt | $4,083 | $4,110 | $3,773 | $3,415 |
| Enterprise Value | $5,365 | $4,777 | $4,937 | $6,986 |
| Revenue | $3 | $13 | $26 | $170 |
| % Growth | -80.1% | -52.3% | -84.6% | – |
| Gross Profit | $0 | -$68 | -$40 | $98 |
| % Margin | 0% | -539.8% | -152.9% | 57.3% |
| EBITDA | -$433 | -$553 | -$543 | -$804 |
| % Margin | -17,300.4% | -4,412.4% | -2,066.8% | -471.6% |
| Net Income | -$826 | $2,302 | -$810 | -$1,892 |
| % Margin | -33,056.4% | 18,368.3% | -3,081.3% | -1,110% |
| EPS Diluted | -0.008 | 0.051 | -0.018 | -0.057 |
| % Growth | -114.8% | 385.6% | 68.6% | – |
| Operating Cash Flow | -$138 | $2,668 | -$239 | -$110 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$138 | $2,668 | -$239 | -$110 |